Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ross Boylan

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
Journal of Neurotrauma|March 27, 2019
Divergent Six Month Functional Recovery Trajectories and Predictors after Traumatic Brain Injury: Novel Insights from the Citicoline Brain Injury Treatment Trial StudyRaquel C Gardner, Jing Cheng, Adam R Ferguson, et al.
Plos One|June 4, 2011
Progression of biopsy-measured liver fibrosis in untreated patients with hepatitis C infection: non-Markov multistate model analysisPeter Bacchetti, Ross Boylan, Jacquie Astemborski, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|December 17, 2008
Fibrosis progression in African Americans and Caucasian Americans with chronic hepatitis CNorah A Terrault, Kelly Im, Ross Boylan, et al.
Plos One|August 16, 2019
Genetic and clinical predictors of CD4 lymphocyte recovery during suppressive antiretroviral therapy: Whole exome sequencing and antiretroviral therapy response phenotypesRuth Greenblatt, Peter Bacchetti, Ross Boylan, et al.
Circulation. Cardiovascular Quality and Outcomes|August 19, 2025
Cost-Effectiveness of Hypertension Treatment According to 2017 American College of Cardiology and American Heart Association GuidelinesJoanne M Penko, Brandon K Bellows, Susan Hennessy, et al.
AIDS (London, England)|November 24, 2015
Enhanced liver fibrosis marker as a noninvasive predictor of mortality in HIV/hepatitis C virus-coinfected women from a multicenter study of women with or at risk for HIVMarion G Peters, Peter Bacchetti, Ross Boylan, et al.
Medrxiv : the Preprint Server for Health Sciences|January 18, 2024
Projected Impact of Nonpharmacologic Management of Stage 1 Hypertension Among Lower-Risk US AdultsKendra D Sims, Pengxiao Carol Wei, Joanne M Penko, et al.
Hypertension (Dallas, Tex. : 1979)|June 17, 2024
Projected Impact of Nonpharmacologic Management of Stage 1 Hypertension Among Lower-Risk US AdultsKendra D Sims, Pengxiao Carol Wei, Joanne M Penko, et al.
JAMA Cardiology|February 4, 2026
Cost-Effectiveness of Semaglutide for Secondary Prevention of Cardiovascular Disease in US AdultsSusan Hennessy, Joanne Penko, Brandon K Bellows, et al.
Circulation|June 14, 2021
Scaling Up Pharmacist-Led Blood Pressure Control Programs in Black Barbershops: Projected Population Health Impact and ValueDhruv S Kazi, Pengxiao C Wei, Joanne Penko, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Journal of Neurotrauma|March 27, 2019
Divergent Six Month Functional Recovery Trajectories and Predictors after Traumatic Brain Injury: Novel Insights from the Citicoline Brain Injury Treatment Trial StudyRaquel C Gardner, Jing Cheng, Adam R Ferguson, et al.
Plos One|June 4, 2011
Progression of biopsy-measured liver fibrosis in untreated patients with hepatitis C infection: non-Markov multistate model analysisPeter Bacchetti, Ross Boylan, Jacquie Astemborski, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|December 17, 2008
Fibrosis progression in African Americans and Caucasian Americans with chronic hepatitis CNorah A Terrault, Kelly Im, Ross Boylan, et al.
Plos One|August 16, 2019
Genetic and clinical predictors of CD4 lymphocyte recovery during suppressive antiretroviral therapy: Whole exome sequencing and antiretroviral therapy response phenotypesRuth Greenblatt, Peter Bacchetti, Ross Boylan, et al.
Circulation. Cardiovascular Quality and Outcomes|August 19, 2025
Cost-Effectiveness of Hypertension Treatment According to 2017 American College of Cardiology and American Heart Association GuidelinesJoanne M Penko, Brandon K Bellows, Susan Hennessy, et al.
AIDS (London, England)|November 24, 2015
Enhanced liver fibrosis marker as a noninvasive predictor of mortality in HIV/hepatitis C virus-coinfected women from a multicenter study of women with or at risk for HIVMarion G Peters, Peter Bacchetti, Ross Boylan, et al.
Medrxiv : the Preprint Server for Health Sciences|January 18, 2024
Projected Impact of Nonpharmacologic Management of Stage 1 Hypertension Among Lower-Risk US AdultsKendra D Sims, Pengxiao Carol Wei, Joanne M Penko, et al.
Hypertension (Dallas, Tex. : 1979)|June 17, 2024
Projected Impact of Nonpharmacologic Management of Stage 1 Hypertension Among Lower-Risk US AdultsKendra D Sims, Pengxiao Carol Wei, Joanne M Penko, et al.
JAMA Cardiology|February 4, 2026
Cost-Effectiveness of Semaglutide for Secondary Prevention of Cardiovascular Disease in US AdultsSusan Hennessy, Joanne Penko, Brandon K Bellows, et al.
Circulation|June 14, 2021
Scaling Up Pharmacist-Led Blood Pressure Control Programs in Black Barbershops: Projected Population Health Impact and ValueDhruv S Kazi, Pengxiao C Wei, Joanne Penko, et al.
Pageof 2